MDPV, mephedrone and naphyrone inhibited complex I and II of the electron transport chain, naphyrone also complex III. All four mitochondrial toxicants were associated with increased mitochondrial ROS and increased lactate production, which was accompanied by a decrease in the cellular total GSH pool for naphyrone and MDPV. In conclusion, bupropion, MDPV, mephedrone and naphyrone are mitochondrial toxicants impairing the function of the electron transport chain and depleting cellular ATP stores. Since liver injury is rare in users of these drugs, affected persons must have susceptibility factors rendering them more sensitive for these drugs.
Introduction
In recent years, various synthetic cathinones ("bath salts", research chemicals) with amphetamine-like properties have emerged on the illicit drug market and have become popular alternatives to classic stimulants among drug users (Baumann et al., 2013; Prosser and Nelson, 2012) . Cathinone designer drugs are derivatives of cathinone (Fig. 1) , a naturally occurring β-keto-amphetamine found in the leaves of the Catha edulis plant, and are chemically and pharmacologically similar to classic illicit stimulants (Baumann et al., 2012; Rickli et al., 2015; Simmler et al., 2013; Simmler et al., 2014) . Therefore, the health risks posed by synthetic cathinones may be similar to the classic stimulants (Liechti, 2015) . A rare, but potentially severe adverse reaction of stimulant use is hepatotoxicity (Andreu et al., 1998; De Carlis et al., 2001; Ellis et al., 1996; Garbino et al., 2001; Jones et al., 1994; Kamijo et al., 2002) . Most research concerning stimulant hepatotoxicity has so far focused on 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy"). However, the hepatotoxic mechanism of MDMA is currently not entirely understood and multiple factors including polydrug abuse, hyperthermia, and metabolism appear to be associated with liver injury in MDMA users (Antolino-Lobo et al., 2011b; Carvalho et al., 2012; Dias da Silva et al., 2013a; Dias da Silva et al., 2013b) . In comparison, data on hepatotoxicity of the newly used synthetic cathinones is currently scarce. A case of acute liver failure after synthetic cathinones use has been described (Fröhlich et al., 2011) and in vitro studies showed that mitochondrial dysfunction and oxidative stress contribute to hepatic injury associated with these compounds (Valente et al., 2016a; Valente et al., 2016b ).
In the current study, we aimed to investigate in more detail the mechanisms of hepatocellular toxicity of several synthetic cathinones ( Fig. 1 ) with a focus on mitochondrial toxicity. We therefore investigated the toxicity of the cathinone designer drugs 3,4-methylenedioxypyrovalerone (MDPV), 4-methylmethcathinone (4-MMC; mephedrone), 4-methoxymethcathinone (4-MeOMC; methedrone), 3,4-5 methylenedioxymethcathinone (βk-MDMA; methylone), and naphthylpyrovalerone (naphyrone) in two human hepatocyte cell lines. In addition, we included bupropion, a synthetic cathinone used as an antidepressant and as a smoking cessation aid.
Methods

Test substances
Naphyrone was synthesized as previously described by Meltzer et al. (Meltzer et al., 2006) . Methylone, mephedrone, methedrone, and MDPV were purchased from Lipomed (Arlesheim, Switzerland) with HPLC purity of >98.5%.
Bupropion was purchased from Cayman Chemicals (Ann Arbor, MI, USA), with a purity of >98%. All drugs were obtained as racemic hydrochloride salts. Drug stocks were made in autoclaved Milli-Q water and were freshly prepared for each assay.
Cell line and culture
The HepG2 cell line was obtained from the American Type Culture Collection (ATCC, Manassas, USA) and cultured in Dulbecco's Modified Eagle Medium (DMEM, 1 g/l glucose) supplemented with 10% heat inactivated fetal calf serum (FCS), 10 mM HEPES buffer, 2 mM GlutaMAX TM , 1% MEM non-essential amino acids, and penicillin-streptomycin (10,000 U/ml corresponding to 10 mg/ml). Cell culture medium and supplements were purchased from Invitrogen (Basel, Switzerland).
The HepaRG cell line was obtained from Biopredic International (Saint Grégoire, France) and cultured in William's E medium (no glutamine) supplemented with 10% FCS, 2 mM L-glutamine, 50 µM hydrocortisone hemisuccinate (Sigma Aldrich, Buchs, Switzerland), 0.05% human insulin (9.5-11.5 mg/ml insulin, Sigma Aldrich), and penicillin-streptomycin (10,000 U/ml corresponding to 10 mg/ml). The 6 cells were cultured at 37 °C in a 5% CO 2 humidified atmosphere and passaged using trypLE TM Express reagent (Invitrogen) when they reached 70-80% confluency.
Cytotoxicity of HepG2 cells
Cytotoxicity was assessed with the ToxiLight BioAssay Kit from Lonza (Basel, Switzerland) and conducted according to the manufacturer's manual. Briefly, 25,000
HepG2 cells per well were seeded in a 96-well plate. The following day, the cells were treated with 100 µl of the test substances dissolved in medium (0.01 mM, 0.1 mM, 1 mM, and 2 mM for each drug and additionally 0.2 mM and 0.5 mM for bupropion and naphyrone). Treatment with 0.5% Triton X-100 was used as a positive control. After 24 h, 50 µl of the ToxiLight assay buffer was added to 20 µl of supernatant and luminescence was measured with a Tecan M200 Pro Infinity plate reader (Männedorf, Switzerland) after 5 min incubation. The luminescence signal was then compared to medium control.
ATP Content in HepG2 cells
The ATP content was assessed with the CellTiter-Glo Luminescent Cell Viability Assay from Promega (Dübendorf, Switzerland) according to the manufacturer's manual. Briefly, 25,000 HepG2 cells per well were seeded in a 96-well plate and cultured overnight. The cells were then treated for 24 h with 100 µl of the test substances dissolved in medium (concentrations as for cytotoxicity).
Treatment with 0.5% Triton X-100 was used as a positive control. Thereafter, 50 µl of the supernatant was discarded and 50 µl of CellTiter-Glo reagent was added to each well. The plate was then shaken for 15 min at room temperature to induce cell lysis.
Thereafter, the luminescent signal was measured with a Tecan M200 Pro Infinity plate reader and compared with medium control.
Cytotoxicity and ATP content in HepaRG cells
HepaRG cells were cultured and differentiated as follows. 10,000 cells per well were seeded in a 96-well plate and the growth medium was replaced with fresh medium every 3-4 days for 2 weeks. Thereafter, the medium was replaced with medium containing 2% of DMSO in order to differentiate the cells into cholangiocyteand hepatocyte-like cells. The medium was again replaced with fresh medium every 3-4 days for 2 weeks and finally replaced with medium containing no DMSO and only 2% FCS. After three days, the medium of some cell preparations was replaced with the same medium containing 20 µM rifampicin (Sigma Aldrich) every 24 h for cytochrome P450 (CYP) induction. The uninduced cell preparations were treated identically with medium not containing rifampicin. After 72 h, the cells were treated with the test drugs (0.01 mM, 0.1 mM 1 mM, and 2 mM), medium control or 0.5%
Triton X-100. The treatment and experimental procedures were the same as described for HepG2 cells.
Mitochondrial membrane potential
The mitochondrial membrane potential (Δψ m ) can be regarded as a global indicator of mitochondrial function (Felser et al., 2013) . Tetramethylrhodamine methyl ester (TMRM; Thermo Scientific, Wohlen, Switzerland) staining was used to measure 
Cellular total glutathione content
Glutathione is an important antioxidant agent; the cellular total glutathione (tGSH) pool consists of reduced (GSH) and oxidized (GSSG) glutathione. Oxidation of GSH is a defense mechanism against cellular stress and a decrease in the GSH content makes cells more vulnerable to toxic agents. The tGSH content was determined with the enzymatic recycling method described by (Rahman et al., 2006 ).
The assay is based on the oxidation of GSH by 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB), which is reduced to the yellow 5'-thio-2-nitrobenzoic acid. Briefly, 750,000
HepG2 cells per well were seeded in a 6-well plate and left to attach overnight. The following day, the cells were treated with 1 ml of test drugs dissolved in medium.
After 24 h, the cells were washed twice with 1 ml of cold PBS and then harvested with 0.05% trypsin-EDTA. Culture medium was added, the cell suspension was transferred into pre-chilled polypropylene tubes, and centrifuged at 1000g and 4 °C for 5 min. The supernatant was discarded and the cells re-suspended in cold PBS.
The cells were centrifuged again and re-suspended in 1 ml of cold extraction buffer (0.1% Triton X-100 and 0.6% sulfosalicylic acid in 0.1 M potassium phosphate buffer with 5 mM EDTA disodium salt, pH 7.5 [KPE]). After two freeze-thaw cycles, the cells were centrifuged at 3000g and 4 °C for 4 min and the supernatant was then immediately transferred into a fresh polypropylene tube. At this point, the cell extracts could be frozen at -80 °C until further use for up to 10 days. To measure tGSH, 20 µl of standards (0.103-26.4 µM GSH in KPE and blank) and 20 µl of the cell extracts were added to a 96-well plate. 100 µl of a DTNB-glutathione reductase (GR) solution (2 mg DTNB and 10 µl of GR [9.5 mg protein/ml; 189 units/mg protein] in 6 ml KPE)
were added to each well. After 30 seconds, 50 µl of a β-nicotinamide adenine dinucleotide 2′-phosphate (β-NADPH) solution (2 mg of β-NADPH tetrasodium salt hydrate in 3 ml of KPE) was added to each well. Immediately thereafter, the absorbance at 412 nm was measured with a Tecan M200 Pro Infinity plate reader every 0.5 min for 2 min. The protein content was determined with the Pierce Protein Assay Kit (Thermo Fisher) and the tGSH content was then adjusted to protein.
Oxygen consumption
The oxygen consumption rate (OCR) was measured with a Seahorse XF24 extracellular flux assay kit (Seahorse Biosciences, North Billerica, MA, USA).
100,000 HepG2 cells per well were seeded in a Seahorse XF24 cell culture microplate coated with poly-D-lysine. The following day, the cells were treated with the test drugs. After 24 h, the medium was removed and the cells were washed with unbuffered DMEM (4 mM L-glutamate, 1 mM pyruvate, 1 g/l glucose, 63.3 mM sodium chloride, pH 7.4), pre-warmed to 37 °C. Thereafter, unbuffered DMEM was added to the cells and the plate was incubated for 40 min at 37 °C in a CO 2 free incubator. The ports of the XF24 assay cartridge were then loaded with oligomycin, FCCP, or rotenone in order to reach a final concentration of 1 µM for each of these compounds. The XF24 Assay cartridge was loaded into a Seahorse XF24 Analyzer (Seahorse Biosciences) and the program was run according to the instructions. The oxidative leak was determined after inhibition of the mitochondrial phosphorylation by oligomycin and the maximal respiration was determined after stimulation of the electron transport chain by FCCP. Extramitochondrial respiration was determined after complex I inhibition by rotenone and subtracted from basal, leak, and maximal respiration. The protein content was determined using sulforhodamine B (SRB)
staining. The cells were fixed with 100 µl of 50% (w/v) trichloroacetic acid (TCA) added directly to the assay medium of each well. After incubation for 1 h at 4 °C, the cells were washed with deionized water and then stained with 0.4% (w/v, in 1% [v/v] acetic acid) SRB. After 20 min, the cells were rapidly washed with 1% (v/v) acetic acid and the incorporated dye was solubilized with 100 µl of 10 mM TRIS base. The absorbance was then measured at 490 nm.
Activity of specific enzyme complexes of the mitochondrial electron transport chain
The activity of specific enzyme complexes of the mitochondrial respiratory chain was analyzed using an Oxygraph-2k high-resolution respirometer equipped with DataLab software (Oroboros instruments, Innsbruck, Austria). HepG2 cells were treated with test drugs for 24 h and afterwards re-suspended in MiR05 (mitochondrial respiration medium containing 0.5 mM EGTA, 3 mM magnesium chloride, 20 mM taurine, 10 mM potassium dihydrogen phosphate, 20 mM HEPES, 110 mM sucrose, 1 g/l fatty-acid free bovine serum albumin, and 60 mM lactobionic acid, pH 7.1). The cells were then transferred into the pre-calibrated Oxygraph chamber (Pesta and Gnaiger, 2012) . Digitonin (10 µg/1 million cells) was used to permeabilize the cells.
Complexes I and III were analyzed using L-glutamate and malate (10 and 2 mM, respectively) as substrates followed by the addition of adenosine-diphosphate (ADP; 2.5 mM) and rotenone (0.5 µM) as an inhibitor of complex I. Duroquinol (0.5 mM)
was then added as a substrate of complex III. Complexes II and IV were analyzed using succinate (10 mM) as substrate and rotenone (0.5 µM) as a complex I inhibitor, followed by the addition of ADP (2.5 mM). After the addition of the complex III inhibitor antimycin A (2.5 µM), N,N,N',N'-tetramethyl-1,4-phenylendiamine and ascorbate (0.5 and 2 mM, respectively) were added to investigate complex IV activity. The absence of a stimulatory effect of exogenous cytochrome c (10 µM) on respiration confirmed integrity of the outer mitochondrial membrane. Protein content was determined with the Pierce Protein Assay Kit. Respiration was expressed as oxygen consumption per mg protein.
ROS production
ROS production was determined with the red mitochondrial superoxide (O 2 -)
indicator MitoSOX (Invitrogen) according to the manufacturer's manual. MitoSOX red is a live-cell permeant fluorogenic dye that targets the mitochondria and exhibits red fluorescence upon oxidation by superoxide. The seeding and treatment conditions were the same as described for cytotoxicity and ATP assays with HepG2 cells;
however, 50 µM amidarone was used as a positive control. Briefly, 100 µl of MitoSOX reagent (2.5 µM) were added to each well of the 96-well plate and incubated for 10 min at 37 °C in the dark. After that, the fluorescence was measured at 510/580 nm with a Tecan M200 Pro Infinity plate reader. The protein content was assessed with the Pierce Protein Assay Kit.
Lactate Determination
Lactate concentrations in the cell culture assay were determined with an enzymatic assay after protein precipitation (Olsen, 1971) . Briefly, 50 µl of supernatant from the MitoSOX assay were diluted with 50 µl of 6% (v/v) perchloric acid (PCA), vortexed, and centrifuged at 3000g for 15 min. Reagent buffer consisting of 100 µl hydrazine buffer (6.8 mM EDTA, 100 mM hydrazine sulphate 1 M hydrazine hydrate, pH 9), 0.2 mg NAD + (free acid; Roche diagnostics, Rotkreuz, Switzerland) and 1 µl LDH (5 mg/ml; Roche diagnostics) were added to 10 µl of sample in a 96-well plate. After 30 min incubation at room temperature, the absorbance was measured and compared to a lactic acid standard curve.
Statistics
Data are presented as mean ± SEM and statistical analyses were performed using GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA). The activity of the enzyme complexes of the mitochondrial electron transport chain was compared to vehicle control with an unpaired two-tailed Student's t-test. For the remaining assays, means were compared to control and differences between control and test drugs were calculated with ANOVA followed by Dunett's test. P-values below 0.05 were considered statistically significant.
Results
Cytotoxicity and ATP content in HepG2 cells
AK release and cellular ATP content were determined as markers for cytotoxicity and mitochondrial function, respectively. In HepG2 cells after 24 h of exposure, all cathinones were cytotoxic and decreased the cellular ATP content in a concentration-dependent manner ( Fig. 2a-d ; Fig. 3a, 3b ; Table 1 ). Bupropion was cytotoxic starting at 2 mM while a decrease in ATP was observed already at 0.5 mM (Fig. 2a) . For MDPV, we observed cytotoxicity starting at 2 mM and a decrease in ATP already at 1 mM (Fig. 2b) . Mephedrone was cytotoxic starting at 2 mM and decreased ATP at 1 mM (Fig. 2c) . Naphyrone was cytotoxic at 0.5 mM and decreased ATP levels at 0.2 mM (Fig. 2d ). For methedrone, we observed cytotoxicity and a decrease in ATP content starting at 2 mM (Fig. 3a) . Methylone was cytotoxic at 2 mM without significant alteration in ATP content (Fig. 3b) . In summary, a decrease in the cellular ATP content at non-cytotoxic drug concentrations, which is compatible with mitochondrial toxicity (Felser et al., 2013; Kamalian et al., 2015) , was observed for bupropion, MDPV, mephedrone, and naphyrone.
Cytotoxicity and ATP content in HepaRG cells
HepaRG were less susceptible than HepG2 cells to the toxicants investigated. After 24 h of drug exposure, we observed cytotoxicity only for bupropion and naphyrone and a decrease in ATP content additionally for MDPV (Fig. 2a, 2b,   2d ; Table 1 ). Bupropion was cytotoxic starting at 2 mM with a decrease in the ATP content at 1 mM (Fig. 2a) . MDPV decreased ATP at starting 2 mM without being cytotoxic (Fig. 2b) . For naphyrone, we observed cytotoxicity and a decrease in ATP content starting at 1 mM (Fig. 2d) . As in HepG2 cells, bupropion and MDPV decreased ATP content at non-cytotoxic drug concentrations, underlining possible mitochondrial toxicity for these toxicants (Felser et al., 2013; Kamalian et al., 2015) .
Induction of drug-metabolizing enzymes with 20 µM rifampicin (Berger et al., 2016) prior to treatment with the toxicants did not cause a difference in cytotoxicity or decrease in the ATP content compared to non-induced cells (data not shown). Since
CYP induction in HepaRG cells did not seem to play a major role in toxicity and
HepG2 cells were more sensitive to the toxicants, we decided to continue our investigations in HepG2 cells only.
Effect on mitochondrial membrane potential
Next, we determined the effect of the synthetic cathinones on the mitochondrial membrane potential (Δψ m ) to further investigate a possible role of mitochondria in cellular ATP reduction. HepG2 cells treated for 24 h showed a decreased Δψ m for bupropion, MDPV, and naphyrone (Fig. 4a, 4b, 4f ). Bupropion reduced the Δψ m starting at 0.5 mM (Fig. 4a ), MDPV at 1 mM (Fig. 4b) , and naphyrone at 0.2 mM (Fig. 4f) . Mephedrone, methedrone, and methylone did not cause a decrease of Δψ m at concentrations up to 1 mM (Fig. 4c, 4d, 4e ). The uncoupler FCCP (9 µM) that we included as positive control reduced the Δψ m by 42% (data not shown).
Effect on cellular oxygen consumption
A decrease in cellular ATP and Δψ m can be caused by impairment and/or uncoupling of the mitochondrial respiratory chain (Felser et al., 2013; Krähenbühl, 14 2001) . We therefore assessed the effect of cathinones on the mitochondrial respiratory chain using a XF24 analyzer. Considering the observed decrease in the cellular ATP content at non-cytotoxic concentrations and/or decreased Δψ m , we tested bupropion, MDPV, mephedrone, and naphyrone at various concentrations ( Fig. 5a-d) . Bupropion caused an increase in leak respiration at 0.8 mM (Fig. 5a ), suggesting uncoupling of oxidative phosphorylation. Mephedrone decreased the basal respiration at 1 mM and the maximal respiration at 0.5 and 1 mM (Fig. 5c ).
Naphyrone decreased the maximal respiration at 0.05 mM, 0.1 mM, and 0.2 mM (Fig. 5d) . MDPV decreased the maximal respiration as well, but without reaching statistical significance (Fig. 5b ).
As shown, methedrone and methylone neither decreased ATP at non-cytotoxic concentrations (Fig. 3a, 3b ) nor did they disrupt Δψ m (Fig. 4d, 4e ). We therefore investigated the oxygen consumption of these substances only at the highest noncytotoxic concentration (1 mM) and we did not find any difference compared to control incubations (data not shown).
We then determined the activity of the complexes of the mitochondrial electron transport chain for bupropion, MDPV, mephedrone, and naphyrone using a highresolution respiratory system (Fig. 6a-h ). Bupropion (0.5 mM), MDPV (1 mM), and mephedrone (1 mM) inhibited complex I and complex II activity (Fig. 6a-f ). At 0.2 mM, naphyrone inhibited complex I, complex II, and complex III activity (Fig. 6g, 6h) .
Effect on lactate and ROS production and cellular GSH
Depending on its extent, the inhibition of the electron transport chain can have several metabolic consequences. Cells try to compensate the loss of mitochondrial ATP production by increasing glycolysis, resulting in increased lactate concentrations in the supernatant, the end product of glycolysis (Felser et al., 2014) .
In addition, inhibition of complex I and complex III of the electron transport chain can stimulate intra-mitochondrial ROS production (Dröse and Brandt, 2012 ).
Accumulating superoxide anion is then metabolized by SOD2 to hydrogen peroxide, which can be reduced by gluthione peroxidase, leading to a decrease in reduced (GSH) and an increase in oxidized glutathione (GSSG). The cellular content of GSH is therefore a measure of oxidative stress (Rahman et al., 2006) . Bupropion caused an accumulation of superoxide and lactate at 0.5 mM but without affecting cellular GSH (Fig. 7a) . For MDPV, we detected increased lactate concentrations at 1 mM as well as increased superoxide levels which were accompanied by a decrease in GSH at 2 mM (Fig. 7b) . Mephedrone stimulated lactate and superoxide production at 1 mM without a significant decrease in GSH up to 2 mM (Fig. 7c) . Naphyrone stimulated lactate and superoxide production already at 0.2 mM with a simultaneous decrease in GSH (Fig. 7d ). Buthionine sulfoximine (BSO), which we used as a positive control, decreased GSH to 14.1 nmol per mg protein, which corresponds to an 83% decrease compared to control incubations (data not shown).
Discussion
Our Regarding CYP induction, it is however important to be aware that CYP2D6 cannot be induced with rifampicin (Berger et al., 2016) . CYP2D6 has been shown to be an important enzyme regarding the metabolism of synthetic cathinones (Helfer et al., 2015; Meyer et al., 2010; Negreira et al., 2015; Pedersen et al., 2013a; Pedersen et al., 2013b) and it is therefore possible that the production of toxic metabolites may have been missed. For instance, the catechol metabolite of MDMA which is formed
by CYP2D6, appears to be more hepatotoxic than the parent compound (AntolinoLobo et al., 2011a; Carmo et al., 2006) .
In accordance with our results, a recently published study has also shown that HepaRG cells are quite resistant to cytotoxicity elicited by synthetic cathinones, with EC 50 concentrations >2 mM and >5 mM for MDPV and methylone, respectively, determined through the MTT reduction assay (Valente et al., 2016a) . We therefore also used HepG2 cells for our investigations, as they represent a good in vitro model for studying the effect of toxicants on mitochondrial function (Felser et al., 2013; Kamalian et al., 2015) . In the current study, cytotoxicity was observed in HepG2 cells for all test drugs in a concentration-dependent manner, which, with the exception of methylone, was accompanied by ATP depletion. For bupropion, MDPV, mephedrone, and naphyrone, ATP depletion was observed at lower concentrations than cytotoxicity, suggesting mitochondrial dysfunction (Felser et al., 2013; Kamalian et al., 2015) . For bupropion, MDPV, and naphyrone, ATP depletion was accompanied by a decrease in Δψ m , further supporting the hypothesis that these compounds cause mitochondrial dysfunction. Since a decrease in Δψ m can be due to impaired activity of the mitochondrial electron transport chain, we investigated the effects of the toxicants on oxidative metabolism of HepG2 cells in more detail. For bupropion, the cellular oxygen consumption in the presence of the complex I substrates L-glutamate and pyruvate revealed an increase in leak respiration, suggesting uncoupling of oxidative phosphorylation. For mephedrone, we observed a decrease in basal and maximal respiration and for naphyrone a decrease in maximal respiration, compatible with inhibition of the electron transport chain. For MDPV, there was a numeric decrease in maximal respiration, which did not achieve statistical significance due to a high variation in the control samples. MDPV was associated with an increase in mitochondrial ROS production and cellular generation of lactate, both indirect markers of a decreased function of the mitochondrial electron transport chain and mitochondrial ATP production (Felser et al., 2013; Felser et al., 2014) . Using high-resolution respirometry, inhibition of complex I and II of the electron transport chain by bupropion, MDPV, mephedrone, and naphyrone and inhibition of complex III by naphyrone could be shown directly. In comparison, methedrone and methylone did not affect the enzyme complexes of the respiratory chain. Methedrone and methylone did not cause ATP depletion at non-cytotoxic concentrations either, nor did they alter Δψ m or the cellular oxygen consumption at 1 mM. For methedrone and methylone, effects on mitochondria can therefore most likely not explain cytotoxicity.
The inhibition of complex I and III of the mitochondrial respiratory chain can be associated with increased mitochondrial ROS production (Dröse and Brandt, 2012) , which can lead to a reduction of the mitochondrial and cellular GSH stores and opening of the mitochondrial membrane permeability transition pore (Green and Reed, 1998 ). In the current study, increased ROS production was observed for all mitochondrial toxicants (bupropion, MDPV, mephedrone, and naphyrone), but a significant decrease in the cellular GSH pool was only detected for MDPV and naphyrone. In support of our results, MDPV has previously been shown to stimulate ROS and RNS production and to deplete the cellular GSH stores in primary rat hepatocytes (Valente et al., 2016b) .
A second consequence of the inhibition of the mitochondrial function is a shift in the ATP production from mitochondria to glycolysis with a concomitant increase in lactate production (Felser et al., 2014) . As expected, the lactate concentration in the supernatant of the incubations containing one of the four compounds affecting mitochondrial function increased significantly, paralleling the increase in ROS production (Fig. 7) .
Among the four compounds affecting mitochondrial function, bupropion has most often been associated with liver injury (Alonso Rodriguez et al., 2010; Alvaro et al., 2001; Carlos Titos-Arcos et al., 2008; Hu et al., 2000; Humayun et al., 2007; Khoo et al., 2003) . The results of the current study suggest that this may more likely be due to the broad use of this compound as a drug than due to a more pronounced mitochondrial toxicity compared to the other cathinones investigated. Bupropion was the only compound, however, that not only inhibited complex I and II of the electron transport chain, but also uncoupled oxidative phosphorylation, which may increase its toxicity.
For all compounds investigated, hepatic toxicity is a rare, but potentially lifethreatening event. Certain factors may therefore increase the probability to develop liver injury when ingesting these compounds. One of these factors is the dose, as suggested by the concentration-dependent toxicity observed in the current study.
Other factors reported in the literature suggested to increase the risk of liver toxicity include polydrug abuse and hyperthermia (Armenian et al., 2013; Borek and Holstege, 2012; Dias da Silva et al., 2013a; Dias da Silva et al., 2013b; Green et al., 2004; Prosser and Nelson, 2012) . CYP2D6 activity could also play a role, since, as discussed previously, the catechol metabolites of methylenedioxy cathinones (MDPV and methylone in the current study) may be more toxic than the respective parent compounds (Antolino-Lobo et al., 2011a; Carmo et al., 2006) . CYP2D6 ultrarapid metabolizers may therefore be at risk for hepatotoxicity associated with these compounds. If mitochondrial dysfunction is a main toxicological mechanism, as suggested by the current study, also preexisting mitochondrial dysfunction may render patients more suceptible. This has been shown for severe hepatotoxicity induced by valproic acid, where preexisting mitochondrial dysfunction is an established suceptibility factor (Krahenbuhl et al., 2000; Stewart et al., 2010) .
Blood concentrations determined in drug users or post mortem cases were typically lower than the toxic concentrations in our cellular assays (Cawrse et al., 2012; Cosbey et al., 2013; Torrance and Cooper, 2010; Wikström et al., 2010) .
However, a case with post-mortem mephedrone blood concentrations >100 µM has been described (Torrance and Cooper, 2010) and in a series of methylone associated fatalities, drug concentrations in the liver were higher than in the blood, with an average liver-to-blood ratio of 2.68 (Cawrse et al., 2012) . Moreover, HepG2 cells appear to be more robust to toxicants than human hepatocytes (Gerets et al., 2012) and the presence of suceptibility factors may shift the blood or liver concentration-toxicity curve to lower concentrations.
In conclusion, our investigations give a closer insight into the mechanism of cathinone-induced hepatotoxicity and demonstrate that bupropion, MDPV, mephedrone and naphyrone are associated with mitochondrial dysfunction due to interactions with enzyme complexes of the electron transport chain. Since liver injury is rare in persons ingesting these compounds, users with liver injury have to have risk factors rendering them more suceptible. Mitochondrial membrane potential after 24 h drug exposure expressed as mean ± SEM of at least three independent experiments compared to vehicle control.
Differences between control and test drugs were calculated with ANOVA followed by Dunett's test. Significance levels are given as **p<0.01, ***p<0.001. Oxygen consumption rate (OCR) in HepG2 cells after 24 h drug exposure. Data are expressed as mean ± SEM of at least four independent experiments. Basal respiration, leak respiration, and maximal respiration were determined after drug treatment as specified in Methods and were compared to the respective vehicle control values. Statistical significance was calculated with ANOVA followed by Dunett's test and significance levels are given as *p<0.05, **p<0.01, ***p<0.001. with an unpaired two-tailed Student's t-test. Significance levels are given as *p<0.05, **p<0.01, ***p<0.001.
Fig. 7. Cellular stress and tGSH content in HepG2 cells
Superoxide production, lactate concentrations and total GSH levels after 24 h drug treatment. Data are expressed as mean ± SEM of at least three independent experiments compared to vehicle control. Statistical significance was calculated with ANOVA followed by Dunett's test and significance levels are given as *p<0.05, **p<0.01, ***p<0.001 for superoxide production and GSH and ## p<0.01, ### p<0.001 for lactate production. 
Complex IV disruption
The concentrations (mM) indicated in the Table correspond to the lowest concentration where a significant toxic effect was recorded. The data are obtained from Fig. 2 to Fig. 7 . Where no concentration is listed, no significant toxicity was observed in the concentration range investigated.
